This website is intended for HCP use alone and Alcon shall not be liable for any actions arising from unadvised and unsupervised use of the material provided here. Please refer to relevant products Directions for Use or Operator’s manuals for complete list of indications, contraindications and warnings.
KEY TAKEAWAY POINTS
- The global burden of cataracts is rising, with cases projected to increase until 2050, highlighting the need for effective and accessible platforms for surgical treatment
- The Legion Vision System is a compact gravity-based phacoemulsification platform that uses: – OZil torsional phacoemulsification technology, including the OZil Intelligent Phaco (IP) software – Centurion-based fluidics
- Comparative laboratory studies show that the Legion system: – recovers faster from surge events and provides superior surge protection across multiplevacuum thresholds compared to the Infiniti system – demonstrated comparable or lower surge volumes than other phacoemulsification platforms#, especially at aggressive settings
- Comparative clinical studies show that the Legion system: – outperformed other systems* in intraoperative efficiency – either matched or outperformed other systems* in early postoperative outcomes